✨ Free AI Report
ProKidney Corp.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview ProKidney Corp.
Research Preview

ProKidney Corp.: Business Overview, Financials & Competitive Analysis

ProKidney Corp. is a clinical-stage biotechnology company that develops a cell therapy platform for the treatment of multiple chronic kidney diseases. The company develops therapies that repair and restore diseased ki...

Analyst-debate audio for ProKidney Corp.

AskCyborg analysts argue the bull and bear cases for ProKidney Corp. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
ProKidney Corp. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

ProKidney offers a buy opportunity due to promising Phase 2 data for rilparencel in advanced CKD, strong FDA alignment, and...

Read the full analyst-debate transcript →
Industry Biotechnology / Cell Therapy / Nephrology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest ProKidney Corp. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

ProKidney Corp. Overview

Pro stress-test →

ProKidney Corp. is a clinical-stage biotechnology company that develops a cell therapy platform for the treatment of multiple chronic kidney diseases. The company develops therapies that repair and restore diseased kidneys using a patient's own cells and may prevent or delay dialysis or transplant.

Strategic Profile

Pro stress-test →

Its lead product candidate, rilparencel, is in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. HC Wainwright & Co. initiated coverage with a Buy recommendation, positioning the company as a promising late-stage clinical player targeting a significant unmet medical need in nephrology.

Competitive Landscape

Pro stress-test →

ProKidney competes in the clinical-stage cell therapy space. Direct competitors include other autologous cell therapy developers targeting kidney disease, though ProKidney's lead candidate rilparencel appears positioned as a first-mover in this cell therapy indication with strong FDA alignment.

Industry Context

ProKidney Corp. operates in Biotechnology / Cell Therapy / Nephrology.

Key facts

Founded: 2015 · Headquarters: Winston-Salem, North Carolina · Employees: 204 · Revenue: null · Market cap: $0.761B

What the analysts stress-tested

The top findings that survived the multi-agent debate for ProKidney Corp..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when ProKidney Corp. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Advanced Renal TherapeuticsNephrology-focused biotech company→Kidney Disease Cell TherapyBiotech firm addressing kidney disease pathways→Cell Therapy PlatformsCellular therapeutics developer→

Compare ProKidney Corp. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

ProKidney Corp. operates in Biotechnology / Cell Therapy / Nephrology. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology / Cell Therapy / Nephrology research →
NEW · MCP server

Ask your AI assistant about ProKidney Corp.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare ProKidney Corp. and its top competitor on Cyborg Score”
“What did ProKidney Corp. do this quarter?”
“Is ProKidney Corp. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does ProKidney Corp. do?+
ProKidney Corp. is a clinical-stage biotechnology company that develops a cell therapy platform for the treatment of multiple chronic kidney diseases. The company develops therapies that repair and restore diseased ki...
What is ProKidney Corp.'s Cyborg Score?+
ProKidney Corp. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are ProKidney Corp.'s main competitors?+
Named competitors include Advanced Renal Therapeutics, Kidney Disease Cell Therapy, Cell Therapy Platforms. The full competitive landscape is in the AskCyborg report.
How can I get the full ProKidney Corp. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the ProKidney Corp. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track ProKidney Corp. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9National Bank of Pakistan9RENK Group AG9Lumentum Holdings Inc.9First Abu Dhabi Bank9The Travelers Companies, Inc.9BAE Systems plc9Arista Networks9KLA Corporation9Hermès International S.A.8Enerjisa Enerji A.Ş.8Emirates Central Cooling Systems Corporation8WALLIX Group8StealthGas Inc.8SofWave Medical Ltd.8Himalaya Shipping Ltd.8Bannerman Energy Ltd8Sembcorp Salalah Power & Water Company8MilDef Group